Your browser doesn't support javascript.
loading
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitis.
Sugihara, Takahiko; Nakaoka, Yoshikazu; Uchida, Haruhito A; Yoshifuji, Hajime; Maejima, Yasuhiro; Watanabe, Yoshiko; Amiya, Eisuke; Tanemoto, Kazuo; Miyata, Tetsuro; Umezawa, Natsuka; Manabe, Yusuke; Ishizaki, Jun; Shirai, Tsuyoshi; Nagafuchi, Hiroko; Hasegawa, Hitoshi; Miyamae, Takako; Niiro, Hiroaki; Ito, Shuichi; Ishii, Tomonori; Isobe, Mitsuaki; Harigai, Masayoshi.
Afiliación
  • Sugihara T; Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Nakaoka Y; Division of Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Uchida HA; Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan.
  • Yoshifuji H; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Maejima Y; Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Watanabe Y; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Amiya E; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Tanemoto K; First Department of Physiology, Kawasaki Medical School, Kurashiki, Japan.
  • Miyata T; Department of Cardiovascular Medicine, Graduate School of Medicine, Tokyo, Japan.
  • Umezawa N; Department of Therapeutic Strategy for Heart Failure, The University of Tokyo, Tokyo, Japan.
  • Manabe Y; Department of Cardiovascular Surgery, Kawasaki Medical School, Kurashiki, Japan.
  • Ishizaki J; Department of Medical Education, School of Medicine, International University of Health and Welfare, Chiba, Japan.
  • Shirai T; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Nagafuchi H; Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan.
  • Hasegawa H; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Miyamae T; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Niiro H; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Ito S; Division of Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Ishii T; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Isobe M; Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
  • Harigai M; Department of Medical Education, Kyushu University, Fukuoka, Japan.
Mod Rheumatol ; 32(5): 930-937, 2022 Aug 20.
Article en En | MEDLINE | ID: mdl-34850081
OBJECTIVES: To develop a proposal for remission criteria and a framework for a treat-to-target (T2T) algorithm for Takayasu arteritis (TAK). METHODS: A study group of the large-vessel vasculitis group of the Japanese Research Committee of the Ministry of Health, Labour and Welfare for Intractable Vasculitis consists of 10 rheumatologists, 5 cardiologists, 1 nephrologist, 1 vascular surgeon, 1 cardiac surgeon, and 2 paediatric rheumatologists. A Delphi survey of remission criteria items was circulated among the study group over four reiterations. To develop the T2T algorithm, the study group conducted four face-to-face meetings and two rounds of Delphi together with three patients. RESULTS: Initial literature review resulted in a list of 117 candidate items for remission criteria, of which 56 items with a mean score of ≥4 (0-5) were extracted including disease activity domains and treatment/comorbidity domains. The study group provided six overarching principles for the T2T algorithm, two recommendations on treatment goals, five on evaluation of disease activity and imaging findings including positron emission tomography-computed tomography, and two on treatment intensification. CONCLUSIONS: We developed a T2T algorithm and proposals for standardised remission criteria by means of a Delphi exercise. These will guide future evaluation of different TAK treatment regimens.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Arteritis de Células Gigantes / Arteritis de Takayasu Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Child / Humans País/Región como asunto: Asia Idioma: En Revista: Mod Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Arteritis de Células Gigantes / Arteritis de Takayasu Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Child / Humans País/Región como asunto: Asia Idioma: En Revista: Mod Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Japón